|
|
Home
Search
Study Topics
Glossary
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsored by: |
University of Mississippi Medical Center |
|---|---|
| Information provided by: | University of Mississippi Medical Center |
| ClinicalTrials.gov Identifier: | NCT00392132 |
Purpose
The Infectious Disease Society of America has recently recommended that patients with Human Immunodeficiency Virus (HIV) be screened for kidney disease on a regular basis. Screening involves non-invasive urine and blood test and a screening program has already been initiated here in the University of Mississippi HIV clinic. This study looks at the effect of this new screening program. Our Hypothesis is that screening for kidney disease is a cost effective and important addition to the care of patients with HIV.
| Condition |
|---|
|
HIV Infections Renal Insufficiency, Chronic Proteinuria |
| Study Type: | Observational |
| Official Title: | Impact of Screening Patients With HIV for Kidney Disease |
| Estimated Enrollment: | 1400 |
| Study Start Date: | October 2005 |
| Estimated Study Completion Date: | October 2006 |
| Estimated Primary Completion Date: | October 2006 (Final data collection date for primary outcome measure) |
The Infectious Disease Society of America has recently recommended that patients with Human Immunodeficiency Virus (HIV) be screened for kidney disease on a regular basis. Screening involves non-invasive urine and blood test and a screening program has already been initiated here in the University of Mississippi HIV clinic. However nobody knows for sure whether this will help doctors take better care of patient with HIV.
This study looks at the effect of this new screening program. We want to see how frequently abnormalities are seen on screening, how frequently certain kidney diseases are diagnosed, how often patients are referred to a nephrologist and how often a patient's management is changed by the screening. We will also estimate the cost-benefit ratio of the screening. We will review patient charts to determine what has happened in each case where screening was conducted.
This study will not involve any additional testing.
The benefit of this study will be improving our understanding of kidney disease in HIV. It will help us determine the value of screening for kidney disease and the frequency of certain kidney diseases in HIV in our clinic population.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Contacts and Locations| United States, Mississippi | |
| University of Mississippi Medical Center | |
| Jackson, Mississippi, United States, 39216-4505 | |
| Principal Investigator: | Darren W Schmidt, MD | University of Mississippi Medical Center |
More Information
| Responsible Party: | University of Mississippi Medical Center ( Darren Schmidt, Assistant Professor of Medicine ) |
| Study ID Numbers: | UMMC - HIV and CKD |
| Study First Received: | October 23, 2006 |
| Last Updated: | November 24, 2008 |
| ClinicalTrials.gov Identifier: | NCT00392132 |
| Health Authority: | United States: Institutional Review Board |
|
HIV |
|
Renal Insufficiency Sexually Transmitted Diseases, Viral Urination Disorders Acquired Immunodeficiency Syndrome Immunologic Deficiency Syndromes Virus Diseases Signs and Symptoms |
Proteinuria Urologic Diseases HIV Infections Renal Insufficiency, Chronic Sexually Transmitted Diseases Kidney Diseases Retroviridae Infections |
|
Urological Manifestations RNA Virus Infections Slow Virus Diseases |
Immune System Diseases Lentivirus Infections Infection |
